全文获取类型
收费全文 | 175586篇 |
免费 | 7251篇 |
国内免费 | 319篇 |
专业分类
耳鼻咽喉 | 3114篇 |
儿科学 | 6664篇 |
妇产科学 | 4463篇 |
基础医学 | 24519篇 |
口腔科学 | 5113篇 |
临床医学 | 13286篇 |
内科学 | 31993篇 |
皮肤病学 | 4806篇 |
神经病学 | 16105篇 |
特种医学 | 8979篇 |
外国民族医学 | 24篇 |
外科学 | 29403篇 |
综合类 | 1119篇 |
一般理论 | 39篇 |
预防医学 | 8344篇 |
眼科学 | 4707篇 |
药学 | 12067篇 |
中国医学 | 353篇 |
肿瘤学 | 8058篇 |
出版年
2023年 | 823篇 |
2021年 | 1352篇 |
2020年 | 1240篇 |
2019年 | 1442篇 |
2018年 | 3076篇 |
2017年 | 2528篇 |
2016年 | 3537篇 |
2015年 | 3899篇 |
2014年 | 4124篇 |
2013年 | 5930篇 |
2012年 | 8568篇 |
2011年 | 8001篇 |
2010年 | 4886篇 |
2009年 | 3860篇 |
2008年 | 7831篇 |
2007年 | 8636篇 |
2006年 | 8737篇 |
2005年 | 9096篇 |
2004年 | 8633篇 |
2003年 | 8511篇 |
2002年 | 8412篇 |
2001年 | 6298篇 |
2000年 | 6358篇 |
1999年 | 5513篇 |
1998年 | 1664篇 |
1997年 | 1377篇 |
1996年 | 1069篇 |
1995年 | 871篇 |
1994年 | 825篇 |
1992年 | 2468篇 |
1991年 | 2384篇 |
1990年 | 2336篇 |
1989年 | 2189篇 |
1988年 | 1911篇 |
1987年 | 1883篇 |
1986年 | 1762篇 |
1985年 | 1683篇 |
1984年 | 1338篇 |
1983年 | 1063篇 |
1979年 | 1422篇 |
1978年 | 1031篇 |
1977年 | 881篇 |
1975年 | 1103篇 |
1974年 | 1150篇 |
1973年 | 1043篇 |
1972年 | 1041篇 |
1971年 | 1008篇 |
1970年 | 911篇 |
1969年 | 838篇 |
1968年 | 812篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Yilmaz Hülya Fırtına Sinem Sarıtaş Merve Sayitoğlu Müge Ar Muhlis Cem 《Immunologic research》2022,70(6):811-816
Immunologic Research - Hyper immunoglobulin M (HIGM) syndrome is a rare disorder of the immune system with impaired antibody functions. The clinical picture of the patients varies according to the... 相似文献
2.
Clinical Rheumatology - Aimed to evaluate the time elapsed between the onset of early symptoms and the diagnosis of fibromyalgia syndrome (FMS), the delays in diagnosis and frequent physician... 相似文献
3.
4.
Münch F. Purbojo A. Wenzel F. Kohl M. Dittrich S. Rauh M. Zimmermann R. Kwapil N. 《Der Anaesthesist》2022,71(11):882-892
Die Anaesthesiologie - Die Transfusion von Erythrozytenkonzentraten (EK) ist mit verschiedenen Nebenwirkungen assoziiert, die u. a. durch Lagerungsschäden an Erythrozyten hervorgerufen... 相似文献
5.
Robert J. Motzer MD David F. McDermott MD Bernard Escudier MD Mauricio Burotto MD Toni K. Choueiri MD Hans J. Hammers MD PhD Philippe Barthélémy MD PhD Elizabeth R. Plimack MD Camillo Porta MD Saby George MD Thomas Powles MD Frede Donskov MD PhD Howard Gurney MD Christian K. Kollmannsberger MD Marc-Oliver Grimm MD Carlos Barrios MD Yoshihiko Tomita MD PhD Daniel Castellano MD Viktor Grünwald MD PhD Brian I. Rini MD M. Brent McHenry PhD Chung-Wei Lee MD PhD Jennifer McCarthy MA Flavia Ejzykowicz PhD Nizar M. Tannir MD 《Cancer》2022,128(11):2085-2097
6.
Georg Prokop Benedikt Wiestler Daniel Hieber Fynn Withake Karoline Mayer Jens Gempt Claire Delbridge Friederike Schmidt-Graf Nicole Pfarr Bruno Märkl Jürgen Schlegel Friederike Liesche-Starnecker 《International journal of cancer. Journal international du cancer》2023,153(9):1658-1670
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered. 相似文献
7.
8.
9.
Tugce Sirin Korucu Sevtap Gunay Ucurum Engin Tastaban Hedef Ozgun Derya Ozer Kaya 《Clinical breast cancer》2021,21(3):e285-e293
IntroductionLymphedema is the most important complication seen after breast cancer surgery. The study aimed to evaluate pain, shoulder-arm complex function, and scapular function in women who developed lymphedema after breast cancer surgery and to compare these with women without lymphedema.Materials and MethodsFifty women with lymphedema (age, 54.34 ± 9.08 years; body mass index, 30.10 ± 4.03 kg/cm2) and 57 women without lymphedema (age, 53.68 ± 9.41 years; body mass index, 29.0 ± 5.44 kg/cm2) after unilateral surgery for breast cancer were included. Clinical and demographic information was noted. The severity of lymphedema with perimeter measurements (Frustum model), level of heaviness discomfort sensation with a visual analog scale, pain threshold with a digital algometer, shoulder-arm complex functionality with the Disabilities of the Arm, Shoulder, Hand Problems Survey (DASH), and scapular function with observational scapular dyskinesia and lateral scapular sliding tests were assessed. The t test, χ2 test, and Mann-Whitney U test were used for analyses.ResultsThe follow-up duration after the surgery was 4.24 ± 2.97 years and 3.19 ± 1.76 years, and the upper extremity volume was 2106.65 ± 510.82 cm3 and 1725.92 ± 342.49 cm³ in the lymphedema group and in the no-lymphedema group, respectively. In the lymphedema group, arm-heaviness discomfort, pain threshold levels in the trapezius and deltoid muscles, and DASH scores were worse (P < .05). The rate of scapular dyskinesia (70.0%) and type 2 scapula (32%) in the surgical side was higher in patients with lymphedema.ConclusionThe pain pressure threshold in the trapezius and deltoid muscles, heaviness sensation level, and inadequate upper extremity function are significantly higher in patients with lymphedema, and the scapular dyskinesia rate was higher. 相似文献
10.
There have been a number of investigations of the efficacy and safety of etanercept. This study was performed to obtain long-term drug survival data (ie, time to drug discontinuation) for etanercept, and the reasons for its discontinuation. The study population consisted of patients with psoriatic arthritis and psoriasis followed up by our clinic, registered in the Turkish Psoriasis Registry (PSR-TR) and treated with etanercept for at least 4 weeks between January 1, 2005, and January 31, 2020. The efficacy of etanercept was evaluated in terms of the Psoriasis Area and Severity Index (PASI) 75, PASI 90 and PASI 100 response rates at 12, 24, 36, and 48 weeks, and annually thereafter. The behaviors of the patients with respect to the use of etanercept, and the outcomes of those who continued to use it during the COVID-19 pandemic, were also investigated. 相似文献